C3.ai Inc vs McKesson Corporation — how do they compare? C3.ai Inc trades at $10.57 (market cap $1.65B), while McKesson Corporation trades at $895 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 63.7× C3.ai Inc's market cap, and McKesson Corporation pays a 0.42% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | MCK | |
|---|---|---|
Market Cap | $1.65B | $105.14B |
Sector | Technology | Health |
52-Week High | $19.66 | $995.69 |
52-Week Low | $7.76 | $659.01 |
Enterprise Value | $1.08B | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →